LIALDA Side Effects

7000222-X | Renal Failure
on Sep 13, 2010 Male patient from UNITED STATES , weighting 225.8 lb, was diagnosed with colitis and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure. Lialda dosage: . During the same period patient was treated with BENICAR (40 Mg, 1x/day:qd) (View Benicar Review and Benicar Label ), ALEVE (CAPLET) (Unk, 1x/day:qd) (View Aleve (caplet) Review and Aleve (caplet) Label ), GLIPIZIDE (5 Mg, 1x/day:qd) (View Glipizide Review and Glipizide Label ), ENTOCORT EC (9 Mg, 1x/day:qd) (View Entocort Ec Review and Entocort Ec Label ). Patient was hospitalized.

6962074-3 | Abdominal Pain
Patient was taking Lialda (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?) on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 118.0 lb, was diagnosed with gastrointestinal inflammation and. Lialda dosage: 2 Tablets Daily Po.

6830619-X | Heart Rate Irregular, Pharyngeal Oedema, Pyrexia
Adverse event was reported on Jul 09, 2010 by a Female patient taking Lialda (View Usage) (Dosage: 4 Tablets Daily) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 80 years of age, weighting 150.0 lb, After Lialda was administered, patient had the following side effects: heart rate irregular, pharyngeal oedema, pyrexia.

6825875-8 | Diarrhoea, Swelling Face, Swollen Tongue, Vomiting
on Jul 07, 2010 Female patient from UNITED STATES , 63 years of age, weighting 103.0 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, swelling face, swollen tongue, vomiting. Lialda dosage: 4 Per Day Oral. During the same period patient was treated with IMURAN (1 Per Day Oral) (View Imuran Review and Imuran Label ). Patient was hospitalized.


6811299-6 | Dehydration, Gastrointestinal Haemorrhage
on Jun 29, 2010 Female patient from UNITED STATES , 20 years of age, was treated with Lialda (View Usage). Patient had the following side effects: dehydration, gastrointestinal haemorrhage. Lialda dosage: Take 2 Tablets By Mouth Daily.

6752486-5 | Bacterial Infection, Unevaluable Event
Patient was taking Lialda (View Usage). After Lialda was administered, patient had the following side effects: bacterial infection (What is bacterial infection?), unevaluable event on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 99.00 lb, was diagnosed with colitis ulcerative and. Lialda dosage: 4 Pills Daily Po. During the same period patient was treated with CANASA (1 Suppository Daily Rectal) (View Canasa Review and Canasa Label ). Patient was hospitalized.

6735240-X | Cardiac Failure Congestive, Colitis, Condition Aggravated, Ileus, Myalgia, Pneumonia Aspiration, Renal Failure Acute
Adverse event was reported on May 20, 2010 by a Female patient taking Lialda (View Usage) (Dosage: 1.2 Grams 2 Daily Po) was diagnosed with proctocolitis and. Location: UNITED STATES , 90 years of age, weighting 150.0 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, colitis, condition aggravated, ileus, myalgia, pneumonia aspiration, renal failure acute. During the same period patient was treated with WELCHOL (625 Mg Twice Po Bid Po) (View Welchol Review and Welchol Label ), CALCIUM (View Calcium Review and Calcium Label ), GLUCOSAMINE/CHONDROITIN (View Glucosamine/chondroitin Review and Glucosamine/chondroitin Label ).

6699471-X | Gastric Ulcer, Pneumonia, Rectal Haemorrhage
on Apr 16, 2010 Male patient from UNITED STATES , 73 years of age, weighting 179.9 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient had the following side effects: gastric ulcer, pneumonia (What is pneumonia?), rectal haemorrhage. Lialda dosage: 1.2 G, 4x/day, Qid, Oral. Patient was hospitalized.

6697529-2 | Myalgia, Pain In Extremity, Pyrexia
on Mar 17, 2009 Female patient from UNITED STATES , 38 years of age, weighting 101.0 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). After Lialda was administered, patient had the following side effects: myalgia, pain in extremity, pyrexia. Lialda dosage: 2.4 G, 1x/day:qd, Oral, 2.4 G, One Dose, Oral. During the same period patient was treated with ROWASA (View Rowasa Review and Rowasa Label ).

6697527-9 | Pancreatitis
Patient was taking Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis on Mar 24, 2009 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 220.9 lb, was diagnosed with colitis ulcerative and. Lialda dosage: 4.8 G, 1x/day:qd, Oral. During the same period patient was treated with UROCIT K (View Urocit-k Review and Urocit-k Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), COLAZAL (View Colazal Review and Colazal Label ), PROAMATINE (MIDORINE HYDROCHLORIDE) TABLET (View Proamatine (midorine Hydrochloride) Tablet Review and Proamatine (midorine Hydrochloride) Tablet Label ), TYLENOL ARTHRITIS (PARACETAMOL) (View Tylenol Arthritis (paracetamol) Review and Tylenol Arthritis (paracetamol) Label ). Patient was hospitalized.

6697521-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Off Label Use
Adverse event was reported on Nov 25, 2009 by a Female patient taking Lialda (View Usage) (Dosage: 1.2 G, 4x/day:qid, Oral, 1.2 G, 3x/day:tid, Oral) was diagnosed with diarrhoea and. Location: UNITED STATES , 56 years of age, weighting 125.0 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, off label use. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

6697519-X | Pancreatitis
on Jan 15, 2010 Female patient from UNITED STATES , 20 years of age, weighting 127.0 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). After Lialda was administered, patient had the following side effects: pancreatitis. Lialda dosage: . During the same period patient was treated with ALCOHOL(ETHANOL) ORAL LIQUID (Oral) (View Alcohol(ethanol) Oral Liquid Review and Alcohol(ethanol) Oral Liquid Label ).

6696944-0 | Pericarditis
on Mar 04, 2010 Male patient from UNITED STATES , 14 years of age, weighting 110.9 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: pericarditis. Lialda dosage: 4.8 G, 1x/day:qd, Oral. During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ). Patient was hospitalized.

6696924-5 | Pancreatitis
Patient was taking Lialda (View Usage). Patient had the following side effects: pancreatitis on Mar 01, 2010 from UNITED STATES Additional patient health information: Female patient , 21 years of age, weighting 220.0 lb, was diagnosed with proctitis ulcerative and. Lialda dosage: 3.6 G, 1x/day:qd, Oral. Patient was hospitalized.

6696879-3 | Off Label Use, Pancreatitis
Adverse event was reported on Aug 24, 2009 by a Male patient taking Lialda (View Usage) (Dosage: 3.6 G Daily, Oral, 1.2 G, 3x/day:tid, Oral) was diagnosed with crohn's disease (What is crohn's disease?), diarrhoea, arthritis (What is arthritis?) and. Location: UNITED STATES , 61 years of age, weighting 200.0 lb, After Lialda was administered, patient had the following side effects: off label use, pancreatitis. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), REMICADE (View Remicade Review and Remicade Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

6696872-0 | Pancreatitis
on Aug 27, 2009 Male patient from UNITED STATES , 66 years of age, weighting 205.0 lb, was diagnosed with colitis and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Lialda dosage: 1.2 G, 4x/day:qid, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEXIUM (View Nexium Review and Nexium Label ), MOBIC (View Mobic Review and Mobic Label ), ROWASA (View Rowasa Review and Rowasa Label ). Patient was hospitalized.

6696868-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased
on May 13, 2009 Female patient from UNITED STATES , 54 years of age, weighting 149.0 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. Lialda dosage: 4.8 G, 1x/day:qd, Oral. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ).

6696861-6 | Off Label Use, Platelet Count Decreased
Patient was taking Lialda (View Usage). After Lialda was administered, patient had the following side effects: off label use, platelet count decreased on Feb 26, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Lialda dosage: Df, 1x/day:qd, Oral.

6696852-5 | Alopecia, Confusional State, Dizziness, Rectal Haemorrhage
Adverse event was reported on Feb 24, 2009 by a Female patient taking Lialda (View Usage) (Dosage: 2.4 G Daily, Oral) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 33 years of age, weighting 125.0 lb, Patient experienced the following unwanted or unexpected effects: alopecia, confusional state, dizziness (What is dizziness?), rectal haemorrhage. During the same period patient was treated with REMICADE (View Remicade Review and Remicade Label ), XANAX (View Xanax Review and Xanax Label ), AMBIEN (View Ambien Review and Ambien Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6667625-4 | International Normalised Ratio Increased, Prothrombin Time Prolonged
on Mar 03, 2010 Male patient from UNITED STATES , 76 years of age, weighting 164.0 lb, was diagnosed with colitis and was treated with Lialda (View Usage). Patient had the following side effects: international normalised ratio increased, prothrombin time prolonged. Lialda dosage: 4.8 G, 1x/day:qd, Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ).

6636415-0 | Aphonia, Arthralgia, Laryngitis, Migraine, Myalgia, Viral Upper Respiratory Tract Infection
on Mar 05, 2010 Female patient from UNITED STATES , 22 years of age, weighting 125.0 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). After Lialda was administered, patient had the following side effects: aphonia, arthralgia, laryngitis, migraine (What is migraine?), myalgia, viral upper respiratory tract infection. Lialda dosage: 4.8, 1x/day:qd, Oral. During the same period patient was treated with URSODIOL (URSODEOXYCHOLIC ACID) TABLET (View Ursodiol (ursodeoxycholic Acid) Tablet Review and Ursodiol (ursodeoxycholic Acid) Tablet Label ).

6627782-2 | Ovarian Mass
Patient was taking Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian mass on Mar 01, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with colitis ulcerative and. Lialda dosage: 2.4 G, 1x/day;qd, Oral. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), REMICADE (INFLIXIMAB) SOLUTION FOR INJECTION (View Remicade (infliximab) Solution For Injection Review and Remicade (infliximab) Solution For Injection Label ), ENTOCORT (BUDESONIDE) CAPSULE (View Entocort (budesonide) Capsule Review and Entocort (budesonide) Capsule Label ), HUMIRA (ADALIMUMAB) SOLUTION FOR INJECTION (View Humira (adalimumab) Solution For Injection Review and Humira (adalimumab) Solution For Injection Label ).

6611903-1 | Alopecia, Dyspepsia, Dysphonia, Fatigue, Feeling Cold, Feeling Of Body Temperature Change, Jaw Disorder, Joint Swelling, Lethargy
Adverse event was reported on Feb 26, 2010 by a Female patient taking Lialda (View Usage) (Dosage: 1 Tblet Daily) was diagnosed with colitis microscopic and. Location: UNITED STATES , 47 years of age, weighting 190.0 lb, Patient had the following side effects: alopecia, dyspepsia, dysphonia, fatigue, feeling cold, feeling of body temperature change, jaw disorder, joint swelling, lethargy.

6558232-2 | Aphonia, Arthralgia, Cholangitis Sclerosing, Laryngitis, Migraine, Myalgia
on Jan 13, 2010 Female patient from UNITED STATES , 22 years of age, weighting 125.0 lb, was diagnosed with colitis and was treated with Lialda (View Usage). After Lialda was administered, patient had the following side effects: aphonia, arthralgia, cholangitis sclerosing, laryngitis, migraine (What is migraine?), myalgia. Lialda dosage: 4.8 G, 1x/day;qd, Oral. During the same period patient was treated with URSODIOL (URSODEOXYCHOLIC ACID) TABLET (View Ursodiol (ursodeoxycholic Acid) Tablet Review and Ursodiol (ursodeoxycholic Acid) Tablet Label ).

6536861-X | Glaucoma
on Jan 04, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: glaucoma (What is glaucoma?). Lialda dosage: Oral. During the same period patient was treated with OMEPRAZOLE (OMEPRAZOLE) CAPSULE (View Omeprazole (omeprazole) Capsule Review and Omeprazole (omeprazole) Capsule Label ).

6530473-X | Dyspnoea, Heart Rate Irregular, Rash
Patient was taking Lialda (View Usage). Patient had the following side effects: dyspnoea, heart rate irregular, rash (What is rash?) on Jan 06, 2010 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 210.0 lb, was diagnosed with colitis ulcerative and. Lialda dosage: 2 Pills Daily.

6522626-1 | Activated Partial Thromboplastin Time Prolonged, Conjunctival Haemorrhage, Haematuria, International Normalised Ratio Increased, Prothrombin Time Prolonged
Adverse event was reported on Dec 22, 2009 by a Male patient taking Lialda (View Usage) (Dosage: 4.8 G, 1x/day:qd, Oral) was diagnosed with colitis and. Location: UNITED STATES , 76 years of age, weighting 164.0 lb, After Lialda was administered, patient had the following side effects: activated partial thromboplastin time prolonged, conjunctival haemorrhage, haematuria, international normalised ratio increased, prothrombin time prolonged. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ).

6456633-4 | Intraocular Pressure Increased
on Nov 09, 2009 Male patient from UNITED STATES , 66 years of age, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure increased. Lialda dosage: Oral. During the same period patient was treated with OMEPRAZOLE (OMEPRAZOLE) CAPSULE (View Omeprazole (omeprazole) Capsule Review and Omeprazole (omeprazole) Capsule Label ).

6441931-0 | B-cell Lymphoma, Off Label Use
on Nov 03, 2009 Female patient from UNITED STATES , 45 years of age, weighting 160.1 lb, was diagnosed with proctitis ulcerative and was treated with Lialda (View Usage). Patient had the following side effects: b-cell lymphoma, off label use. Lialda dosage: 2.4 G, 1x/day:qd, Oral. During the same period patient was treated with FISH OIL (FISH OIL) (View Fish Oil (fish Oil) Review and Fish Oil (fish Oil) Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6429524-2 | Alpha 1 Foetoprotein Increased, Condition Aggravated, Hepatic Enzyme Increased, Ovarian Cyst, Radical Hysterectomy
Patient was taking Lialda (View Usage). After Lialda was administered, patient had the following side effects: alpha 1 foetoprotein increased, condition aggravated, hepatic enzyme increased, ovarian cyst (What is ovarian cyst?), radical hysterectomy on Oct 23, 2009 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 160.1 lb, was diagnosed with colitis ulcerative and. Lialda dosage: 2.4 G, 1x/day:qd, Oral. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6400945-7 | Haematochezia
Adverse event was reported on Oct 03, 2009 by a Male patient taking Lialda (View Usage) (Dosage: 1.2 G, 1x/d:qd, Oral) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 42 years of age, Patient experienced the following unwanted or unexpected effects: haematochezia. Patient was hospitalized.

6395338-5 | Abdominal Pain Upper, Fall, Feeling Abnormal, Hip Fracture, Joint Injury
on Oct 01, 2009 Female patient from UNITED STATES , 74 years of age, weighting 186.1 lb, was diagnosed with ileitis and was treated with Lialda (View Usage). Patient had the following side effects: abdominal pain upper, fall (What is fall?), feeling abnormal, hip fracture, joint injury. Lialda dosage: 2.4 G, 1x/day:qd, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), SINGULAIR (View Singulair Review and Singulair Label ), NEXIUM (View Nexium Review and Nexium Label ), KLOR CON (View Klor-con Review and Klor-con Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ETODOLAC (View Etodolac Review and Etodolac Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6375597-5 | Abdominal Pain Upper, Arthropathy, Fall, Feeling Abnormal, Hip Fracture, Joint Injury
on Sep 14, 2009 Female patient from UNITED STATES , 64 years of age, weighting 181.9 lb, was treated with Lialda (View Usage). After Lialda was administered, patient had the following side effects: abdominal pain upper, arthropathy, fall (What is fall?), feeling abnormal, hip fracture, joint injury. Lialda dosage: 2.4 G, 1xiday: Qd, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6354002-9 | Diabetic Ketoacidosis, Dyspepsia, Hyperventilation, Underdose, Vomiting
Patient was taking Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis, dyspepsia, hyperventilation, underdose, vomiting on Sep 01, 2009 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 175.0 lb, was diagnosed with colitis ulcerative and. Lialda dosage: 4.8 G, 1x/day:qd, Oral ; 1.2 G, 1x/day:qd, Oral ; 1x/day:qd, Oral. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), LANTUS (View Lantus Review and Lantus Label ), VITAMIN D NOS (VITAMIN D NOS) (View Vitamin D Nos (vitamin D Nos) Review and Vitamin D Nos (vitamin D Nos) Label ). Patient was hospitalized.

6348939-4 | Erythema Nodosum, Haematuria
Adverse event was reported on Aug 20, 2009 by a Male patient taking Lialda (View Usage) (Dosage: 4.8 G, Daily, Oral; 2.4 G, Daily, Oral) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 19 years of age, weighting 142.0 lb, Patient had the following side effects: erythema nodosum, haematuria.

6337345-4 | Anaemia, Arthralgia, Bone Marrow Disorder
on Sep 01, 2009 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with large intestinal ulcer and was treated with Lialda (View Usage). After Lialda was administered, patient had the following side effects: anaemia, arthralgia, bone marrow disorder. Lialda dosage: 4 - 1.2 Gm Tabs Am - Daily Oral.

6337036-X | Angioedema, Lip Swelling, Muscular Weakness, Peripheral Motor Neuropathy
on Aug 24, 2009 Female patient from UNITED STATES , 67 years of age, weighting 143.3 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, lip swelling, muscular weakness, peripheral motor neuropathy. Lialda dosage: 2.4g, 1x/day; Qd, Oral.

6331885-X | Dry Mouth, Hypothyroidism
Patient was taking Lialda (View Usage). Patient had the following side effects: dry mouth, hypothyroidism on Aug 19, 2009 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 134.0 lb, was diagnosed with colitis ulcerative and. Lialda dosage: 4.8 G Daily, Oral. During the same period patient was treated with ASTELIN /00884002/ (AZELASTINE HYDROCHLORIDE) (View Astelin /00884002/ (azelastine Hydrochloride) Review and Astelin /00884002/ (azelastine Hydrochloride) Label ), NASONEX (View Nasonex Review and Nasonex Label ).

6327883-2 | Anxiety, Urethral Meatus Stenosis
Adverse event was reported on Aug 12, 2009 by a Female patient taking Lialda (View Usage) (Dosage: (2 Df Qd Oral)) was diagnosed with colitis ulcerative and. Location: INDIA , weighting 88.18 lb, After Lialda was administered, patient had the following side effects: anxiety (What is anxiety?), urethral meatus stenosis. Patient was hospitalized.

6312574-4 | Dyspepsia, Hyperventilation, Underdose, Urine Ketone Body Present, Vomiting
on Aug 04, 2009 Female patient from UNITED STATES , 34 years of age, weighting 175.0 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: dyspepsia, hyperventilation, underdose, urine ketone body present, vomiting. Lialda dosage: 4.8 G, 1x/day:qd, Oral; 1.2 G, 1x/day:qd, Oral. During the same period patient was treated with HUMALOG /01293501/ (INSULIN LISPRO) INJECTION (View Humalog /01293501/ (insulin Lispro) Injection Review and Humalog /01293501/ (insulin Lispro) Injection Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6310822-8 | Confusional State, Disorientation, Dysgeusia, Eating Disorder Symptom, Muscular Weakness, Nausea, Off Label Use, Retching, Somnolence
on Aug 04, 2009 Female patient from UNITED STATES , 89 years of age, weighting 136.0 lb, was diagnosed with colitis collagenous and was treated with Lialda (View Usage). Patient had the following side effects: confusional state, disorientation, dysgeusia, eating disorder symptom, muscular weakness, nausea (What is nausea?), off label use, retching, somnolence. Lialda dosage: 1.2 G, 1x/day;qd, Oral. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SINGULAIR /01362601/(MONTELUKAST) (View Singulair /01362601/(montelukast) Review and Singulair /01362601/(montelukast) Label ), ATROVENT (IPRATROPIUM BROMIDE) INHALATION GAS (View Atrovent (ipratropium Bromide) Inhalation Gas Review and Atrovent (ipratropium Bromide) Inhalation Gas Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6304089-4 | Abnormal Loss Of Weight, Decreased Appetite, Road Traffic Accident, Tendon Rupture
Patient was taking Lialda (View Usage). After Lialda was administered, patient had the following side effects: abnormal loss of weight, decreased appetite, road traffic accident, tendon rupture on Jul 29, 2009 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 200.0 lb, was diagnosed with colitis ulcerative, crohn's disease (What is crohn's disease?) and. Lialda dosage: G, Oral. During the same period patient was treated with MICARDIS (TELMISSARTAN) (View Micardis (telmissartan) Review and Micardis (telmissartan) Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ).

6282736-3 | Chills, Colitis Microscopic, Condition Aggravated, Disorientation, Micturition Urgency, Pollakiuria, Pyrexia, Tremor
Adverse event was reported on Jul 14, 2009 by a Male patient taking Lialda (View Usage) (Dosage: 4.8 G, 1x/day;qd, Oral) was diagnosed with colitis microscopic and. Location: UNITED STATES , 73 years of age, weighting 179.9 lb, Patient experienced the following unwanted or unexpected effects: chills, colitis microscopic, condition aggravated, disorientation, micturition urgency, pollakiuria, pyrexia, tremor. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), IMODIUM /00384302/ (LOPERAMIDE HYDROCHLORIDE) (View Imodium /00384302/ (loperamide Hydrochloride) Review and Imodium /00384302/ (loperamide Hydrochloride) Label ).

6277849-6 | Pancreatitis Acute
on Jul 17, 2009 Male patient from UNITED STATES , 60 years of age, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient had the following side effects: pancreatitis acute. Lialda dosage: . Patient was hospitalized.

6271994-7 | Blood Creatinine Increased, Brain Natriuretic Peptide, Chest Pain, Demyelinating Polyneuropathy, Dyspnoea, Fatigue, Guillain-barre Syndrome, Haematocrit Decreased, Haemoglobin Decreased
on Jul 01, 2009 Female patient from UNITED STATES , 76 years of age, weighting 168.0 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). After Lialda was administered, patient had the following side effects: blood creatinine increased, brain natriuretic peptide, chest pain (What is chest pain?), demyelinating polyneuropathy, dyspnoea, fatigue, guillain-barre syndrome (What is guillain-barre syndrome?), haematocrit decreased, haemoglobin decreased. Lialda dosage: 4.8 G, 1x/day:qd Am, Oral. During the same period patient was treated with ARIMIDEX (ANASTROZOLE) TABLET (View Arimidex (anastrozole) Tablet Review and Arimidex (anastrozole) Tablet Label ), BUMEX (BUMETANIDE) TABLET (View Bumex (bumetanide) Tablet Review and Bumex (bumetanide) Tablet Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized and became disabled.

6259354-6 | Arrhythmia, Palpitations
Patient was taking Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), palpitations on Jun 25, 2009 from UNITED STATES Additional patient health information: Female patient , 24 years of age, . Lialda dosage: G. Patient was hospitalized.

6256328-6 | Back Pain, Dysstasia, Headache, Hyperhidrosis, Musculoskeletal Pain, Musculoskeletal Stiffness, Pyrexia, Vomiting
Adverse event was reported on Jun 30, 2009 by a Male patient taking Lialda (View Usage) (Dosage: 4 Tables Daily Po) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 32 years of age, weighting 172.0 lb, Patient had the following side effects: back pain (What is back pain?), dysstasia, headache (What is headache?), hyperhidrosis, musculoskeletal pain, musculoskeletal stiffness, pyrexia, vomiting.

6243899-9 | Chest Pain, Guillain-barre Syndrome, Respiratory Failure
on Jun 15, 2009 Female patient from UNITED STATES , 76 years of age, weighting 168.0 lb, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). After Lialda was administered, patient had the following side effects: chest pain (What is chest pain?), guillain-barre syndrome (What is guillain-barre syndrome?), respiratory failure. Lialda dosage: 4.8 G, Daily, Oral. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), INSULIN (INSULIN) INJECTION (View Insulin (insulin) Injection Review and Insulin (insulin) Injection Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ARIMIDEX (ANASTROZOLE) TABLET (View Arimidex (anastrozole) Tablet Review and Arimidex (anastrozole) Tablet Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6235670-9 | Bone Marrow Failure, Colitis Ulcerative, Condition Aggravated
on Jun 08, 2009 Female patient from UNITED STATES , 33 years of age, was diagnosed with colitis ulcerative and was treated with Lialda (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, colitis ulcerative, condition aggravated. Lialda dosage: G, Oral; 2.4 G, 2x/day:bid, Oral.

6235572-8 | Back Pain, Crohn's Disease, Disease Progression, Iron Deficiency Anaemia, Off Label Use
Patient was taking Lialda (View Usage). Patient had the following side effects: back pain (What is back pain?), crohn's disease (What is crohn's disease?), disease progression, iron deficiency anaemia, off label use on Jun 08, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 19 years of age, weighting 162.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Lialda dosage: 4.8 G, 1x/day:qd, Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).